Concepedia

Evita Sadimin

ES

Statistics

Publications

19

Citations

707

H-Index

16

Active since

2012

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Johns Hopkins University

Johnson University

Memorial Sloan Kettering Cancer Center

Evita Sadimin is an author at Rutgers, The State University of New Jersey specializing in medicine, pathology, and diagnosis.

ORCID

Top concepts

Publications per year

2012–2022

19

Publications

19

Renal cell carcinoma: the search for a reliable biomarker

Nicholas Farber, Christopher J. Kim, Parth K. Modi et al. · Translational Cancer Research · 2017 · 109 citations · Full text

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

Mark N. Stein, Jyoti Malhotra, Rohinton S. Tarapore et al. · Journal for ImmunoTherapy of Cancer · 2019 · 70 citations · Full text

Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection <i>In Vivo</i>

Florian Douam, Yentli E. Soto Albrecht, Gabriela Hrebikova et al. · mBio · 2017 · 64 citations · Full text

A phase <scp>II</scp> trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (<scp>GRM</scp>1) signaling, in patients with advanced melanoma

Janice M. Mehnert, Ann W. Silk, J. H. Lee et al. · Pigment Cell & Melanoma Research · 2018 · 51 citations · Full text

VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney

Lisha Wang, Yuping Zhang, Ying‐Bei Chen et al. · The American Journal of Surgical Pathology · 2018 · 48 citations · Full text

, , +14

1–5 of 19